Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Noninvasive IDH1 Mutation Estimation Based On A Quantitative Radiomics Approach For Grade II Glioma

Jinhua Yu, Z. Shi, Y. Lian, Zeju Li, T. Liu, Y. Gao, Y. Wang, L. Chen, Y. Mao
Published 2016 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
ObjectiveThe status of isocitrate dehydrogenase 1 (IDH1) is highly correlated with the development, treatment and prognosis of glioma. We explored a noninvasive method to reveal IDH1 status by using a quantitative radiomics approach for grade II glioma.MethodsA primary cohort consisting of 110 patients pathologically diagnosed with grade II glioma was retrospectively studied. The radiomics method developed in this paper includes image segmentation, high-throughput feature extraction, radiomics sequencing, feature selection and classification. Using the leave-one-out cross-validation (LOOCV) method, the classification result was compared with the real IDH1 situation from Sanger sequencing. Another independent validation cohort containing 30 patients was utilised to further test the method.ResultsA total of 671 high-throughput features were extracted and quantized. 110 features were selected by improved genetic algorithm. In LOOCV, the noninvasive IDH1 status estimation based on the proposed approach presented an estimation accuracy of 0.80, sensitivity of 0.83 and specificity of 0.74. Area under the receiver operating characteristic curve reached 0.86. Further validation on the independent cohort of 30 patients produced similar results.ConclusionsRadiomics is a potentially useful approach for estimating IDH1 mutation status noninvasively using conventional T2-FLAIR MRI images. The estimation accuracy could potentially be improved by using multiple imaging modalities.Key Points• Noninvasive IDH1 status estimation can be obtained with a radiomics approach.• Automatic and quantitative processes were established for noninvasive biomarker estimation.• High-throughput MRI features are highly correlated to IDH1 states.• Area under the ROC curve of the proposed estimation method reached 0.86.
This paper references
10.1109/TMI.2016.2538465
Brain Tumor Segmentation Using Convolutional Neural Networks in MRI Images
Sérgio Pereira (2016)
2015)Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas
WangY (2015)
10.1111/ene.12578
Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel‐based radiographic study of 146 low‐grade gliomas
Y. Wang (2015)
10.1016/j.neuroimage.2010.05.023
Machine learning classification with confidence: Application of transductive conformal predictors to MRI-based diagnostic and prognostic markers in depression
I. Nouretdinov (2011)
10.1093/neuonc/not159
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.
Jason Beiko (2014)
10.1109/4235.996017
A fast and elitist multiobjective genetic algorithm: NSGA-II
K. Deb (2002)
Estimation of IDH1 Mutation Status
K Yamashita (2017)
10.1023/A:1022627411411
Support-Vector Networks
Corinna Cortes (2004)
10.1093/neuonc/nov307
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.
Macarena I de la Fuente (2016)
10.1109/TBME.2015.2485779
MAPS: A Quantitative Radiomics Approach for Prostate Cancer Detection
A. Cameron (2016)
A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities
Z. Zhou (2015)
10.1007/s11060-014-1614-z
Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging
Seunghyun Lee (2014)
10.1007/s00330-015-4046-z
The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis
Q. Wang (2015)
10.1172/JCI67229
Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.
O. Andronesi (2013)
10.1006/nimg.2001.0978
Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain
N. Tzourio-Mazoyer (2002)
10.1145/279943.279960
Improved Boosting Algorithms using Confidence-Rated Predictions
R. Schapire (1998)
10.1038/modpathol.2014.94
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
A. Chan (2015)
10.1109/TPAMI.2005.159
Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy
H. Peng (2005)
10.1634/theoncologist.2014-0266
Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma.
G. Lombardi (2015)
Machine learning classification with confidence: application of transductive conformal predictors to MRI-based diagnostic and prognostic markers in depression. Neuroimage
I Nouretdinov (2011)
10.1148/radiol.2015151169
Radiomics: Images Are More than Pictures, They Are Data
R. Gillies (2016)
10.1007/s10044-015-0492-0
Automated hippocampal segmentation in 3D MRI using random undersampling with boosting algorithm
R. Maglietta (2015)
10.1056/NEJMoa1402121
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
D. Brat (2015)
10.1056/NEJMra0708126
Malignant gliomas in adults.
P. Wen (2008)
Integration of 2hydroxyglutarateproton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenasemutant gli
MI LaFuente (2016)
10.1016/B978-012693019-1/50029-0
A Probabilistic Atlas and Reference System for the Human Brain
J. Mazziotta (2001)
2016) Radiomics: Images Are More thanPictures
RJ Gillies (2015)
10.1016/j.neuroimage.2011.09.076
Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblastomas
B. Ellingson (2012)
10.1007/s11060-011-0737-8
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
W. Pope (2011)
10.1109/TSMC.1973.4309314
Textural Features for Image Classification
R. Haralick (1973)
10.1098/RSTB.2001.0915
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM).
J. Mazziotta (2001)
10.3389/fonc.2015.00272
Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
Chintan Parmar (2015)
10.3174/ajnr.A4065
Mapping p53 Mutations in Low-Grade Glioma: A Voxel-Based Neuroimaging Analysis
Y. Wang (2015)
10.1097/PAP.0000000000000049
The Evolving Molecular Genetics of Low-grade Glioma
S. Venneti (2015)
10.1371/journal.pone.0143308
Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study
J. Wang (2015)
10.1146/ANNUREV.NEURO.24.1.385
The developmental biology of brain tumors.
R. Wechsler-Reya (2001)
10.1016/J.MRI.2003.09.001
Influence of MRI acquisition protocols and image intensity normalization methods on texture classification.
G. Collewet (2004)
10.1038/ncomms5006
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
H. Aerts (2014)
10.1109/CITA.2015.7349827
Feature selection based on mutual information
M. Sulaiman (2015)
10.1007/s00330-016-4328-0
Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging
O. Togao (2016)
A fast and elitist mu l t iob j ec t i ve gene t i c a lgo r i t hm: NSGA- I I
K Deb (2002)
10.3389/fonc.2016.00071
Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology
Weimiao Wu (2016)
10.1016/S1470-2045(13)70168-2
Molecular neuro-oncology in clinical practice: a new horizon.
M. Weller (2013)
MR ImagingBased Analysis of Glioblastoma Multiforme : Estimation of IDH 1 Mutation Status
K Yamashita (2016)
10.3174/ajnr.A4491
MR Imaging–Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status
K. Yamashita (2016)



This paper is referenced by
10.3389/fonc.2019.01183
A Non-invasive Radiomic Method Using 18F-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma
L. Li (2019)
10.1007/978-3-030-24274-9_35
Sparse Representation-Based Radiomics in the Diagnosis of Thyroid Nodules
Y. Cao (2019)
10.3390/cancers11060829
Optimizing Neuro-Oncology Imaging: A Review of Deep Learning Approaches for Glioma Imaging
Madeleine Shaver (2019)
10.3348/kjr.2018.0814
Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors
Y. Park (2019)
10.1016/j.crad.2020.07.036
A radiomics-clinical nomogram for preoperative prediction of IDH1 mutation in primary glioblastoma multiforme.
X. Su (2020)
10.1109/EMBC.2018.8513556
Deep Learning and Multi-Sensor Fusion for Glioma Classification Using Multistream 2D Convolutional Networks
Chenjie Ge (2018)
10.1007/s00259-019-04372-x
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics
M. Sollini (2019)
10.23838/PFM.2017.00101
Radiomics and imaging genomics in precision medicine
G. Lee (2017)
10.1007/s00330-019-06558-1
Preoperative prediction of tumour deposits in rectal cancer by an artificial neural network–based US radiomics model
Li-Da Chen (2019)
10.1016/j.radonc.2018.03.033
Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score.
S. Sanduleanu (2018)
10.1158/1078-0432.CCR-17-2236
Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging
K. Chang (2017)
10.3390/ijms21218004
MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting
Y. Sakai (2020)
10.1007/s11548-018-1796-5
Comparison of the application of B-mode and strain elastography ultrasound in the estimation of lymph node metastasis of papillary thyroid carcinoma based on a radiomics approach
T. Liu (2018)
10.1016/j.clineuro.2019.105565
Application of Radiomics in Central Nervous System Diseases: a Systematic literature review
Yanghua Fan (2019)
10.3174/ajnr.A5569
Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of IDH1-Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II Gliomas
Y. Park (2018)
10.1038/s41374-020-0472-x
A novel image signature-based radiomics method to achieve precise diagnosis and prognostic stratification of gliomas
Huigao Luo (2020)
10.23736/S1824-4785.18.03095-9
Radiomics derived from amino-acid PET and conventional MRI in patients with high-grade gliomas.
P. Lohmann (2018)
10.1161/CIRCIMAGING.117.006843
Radiomic Features Are Superior to Conventional Quantitative Computed Tomographic Metrics to Identify Coronary Plaques With Napkin-Ring Sign
M. Kolossváry (2017)
Population-based studies of brain tumor surgery: surgical outcome and prognostic factors
Alba Corell (2020)
10.1038/s41598-018-30273-4
Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas
Hideyuki Arita (2018)
10.1007/s00330-019-06056-4
A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery
Y. Tan (2019)
10.1186/s12885-019-6504-5
A systematic review reporting quality of radiomics research in neuro-oncology: toward clinical utility and quality improvement using high-dimensional imaging features
J. Park (2020)
10.1016/j.crad.2018.12.004
Comparing the value of DKI and DTI in detecting isocitrate dehydrogenase genotype of astrocytomas.
Y. Tan (2019)
Prognostic Prediction of Glioblastomas By Using Genes and Image Features
Masatoshi Kondo (2018)
10.1007/s13139-017-0512-7
Radiomics as a Quantitative Imaging Biomarker: Practical Considerations and the Current Standpoint in Neuro-oncologic Studies
J. Park (2018)
10.1007/s00330-018-5608-7
Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis
C. Suh (2018)
10.1016/j.ejrad.2019.108714
Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
C. Jiang (2019)
10.3348/kjr.2019.0847
Radiomics and Deep Learning from Research to Clinical Workflow: Neuro-Oncologic Imaging
J. Park (2020)
10.1007/s11060-019-03096-0
Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas
H. Zhou (2019)
10.1109/ACCESS.2019.2920396
Predicting the Gene Status and Survival Outcome of Lower Grade Glioma Patients With Multimodal MRI Features
A. Chaddad (2019)
10.25777/XGE2-9F89
Model-Based Approach for Diffuse Glioma Classification, Grading, and Patient Survival Prediction
Zeina A. Shboul (2020)
10.1016/j.neurad.2019.05.006
Correlation between Magnetic Resonance Imaging Characteristics and BRAF Alteration Status in Individuals with Optic Pathway/Hypothalamic Pilocytic Astrocytomas.
Yukitomo Ishi (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar